Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.91 is 68% above its 5-year average of -2.83, near the high end of its 5-year range (-6.46–-0.64).
54.16% above its 12-month average of -1.99.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.14.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.91
EARNINGS PER SHARE (EPS) AVG TTM
-1.99
EARNINGS PER SHARE (EPS) AVG 3Y
-3.92
EARNINGS PER SHARE (EPS) AVG 5Y
-2.83
EARNINGS PER SHARE (EPS) AVG 10Y
-1.89
EARNINGS PER SHARE (EPS) AVG 15Y
-0.67
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+54.16%
CURRENT VS 3Y AVG
+76.76%
CURRENT VS 5Y AVG
+67.84%
CURRENT VS 10Y AVG
+51.76%
CURRENT VS 15Y AVG
-36.38%
CURRENT VS 20Y AVG
N/A
Evogene Ltd.
Market Cap
$3.42M
Earnings Per Share (EPS)
-0.91
TTM Avg
-1.99
3Y Avg
-3.92
5Y Avg
-2.83
Market Cap
$3.49M
Earnings Per Share (EPS)
-0.45
TTM Avg
-1.48
3Y Avg
-5.05
5Y Avg
-8.12
Market Cap
$3.45M
Earnings Per Share (EPS)
N/A
TTM Avg
-130.80
3Y Avg
-71.47
5Y Avg
-57.18
Market Cap
$3.55M
Earnings Per Share (EPS)
-14.40
TTM Avg
-19.95
3Y Avg
-16.43
5Y Avg
-17.45
Market Cap
$3.33M
Earnings Per Share (EPS)
-11.70
TTM Avg
-48.19
3Y Avg
-238.41
5Y Avg
-340.02
Market Cap
$3.34M
Earnings Per Share (EPS)
-4.90
TTM Avg
-7.69
3Y Avg
-8.41
5Y Avg
-8.41
Market Cap
$3.28M
Earnings Per Share (EPS)
-6.76
TTM Avg
-8.05
3Y Avg
-9.85
5Y Avg
-9.67
Market Cap
$3.25M
Earnings Per Share (EPS)
N/A
TTM Avg
-1108.98
3Y Avg
-1045.55
5Y Avg
-1171.01
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Evogene Ltd. (EVGN) | $3.42M | -0.91 | -1.99 | -3.92 | -2.83 |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -0.45 | -1.48 | -5.05 | -8.12 |
| Eocene Ltd. (EOCN)vs › | $3.42M | N/A | N/A | N/A | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.45M | N/A | -130.80 | -71.47 | -57.18 |
| Nexalin Technology, Inc. (NXL)vs › | $3.55M | -14.40 | -19.95 | -16.43 | -17.45 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.33M | -11.70 | -48.19 | -238.41 | -340.02 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.34M | -4.90 | -7.69 | -8.41 | -8.41 |
| IceCure Medical Ltd (ICCM)vs › | $3.28M | -6.76 | -8.05 | -9.85 | -9.67 |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.25M | N/A | -1108.98 | -1045.55 | -1171.01 |
| MBody AI Ltd. (MBAI)vs › | $3.21M | N/A | -12.74 | -17.52 | -18.26 |
Trailing EPS (TTM)
$-0.91
Forward EPS (Est.)
$-1.10
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.08 |
| 2024-12-31 | -2.89 |
| 2023-12-31 | -5.23 |
| 2022-12-31 | -6.46 |
| 2021-12-31 | -0.68 |
| 2020-12-31 | -0.64 |
| 2019-12-31 | -0.70 |
| 2018-12-31 | -0.81 |
| 2017-12-31 | -0.81 |
| 2016-12-31 | -0.77 |
| 2015-12-31 | -0.68 |
| 2014-12-31 | -0.58 |
| 2013-12-31 | -0.45 |
| 2012-12-31 | -0.14 |
| 2011-12-31 | 0.04 |
